A comparison of fish oil, flaxseed oil and hempseed oil supplementation on selected parameters of cardiovascular health in healthy volunteers N Kaul, R Kreml, JA Austria, MN Richard, AL Edel, E Dibrov, S Hirono, ... Journal of the American College of Nutrition 27 (1), 51-58, 2008 | 189 | 2008 |
Persistence with secondary prevention medications after acute myocardial infarction: insights from the TRANSLATE-ACS study R Mathews, TY Wang, E Honeycutt, TD Henry, M Zettler, M Chang, ... American heart journal 170 (1), 62-69, 2015 | 142 | 2015 |
Outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention receiving an oral anticoagulant and dual antiplatelet therapy: a comparison … LR Jackson, C Ju, M Zettler, JC Messenger, DJ Cohen, GW Stone, ... JACC: Cardiovascular Interventions 8 (14), 1880-1889, 2015 | 115 | 2015 |
OxLDL stimulates cell proliferation through a general induction of cell cycle proteins ME Zettler, MA Prociuk, JA Austria, H Massaeli, G Zhong, GN Pierce American Journal of Physiology-Heart and Circulatory Physiology 284 (2 …, 2003 | 114 | 2003 |
Pharmacodynamic evaluation of switching from ticagrelor to prasugrel in patients with stable coronary artery disease: results of the SWAP-2 Study (Switching Anti Platelet-2) DJ Angiolillo, N Curzen, P Gurbel, P Vaitkus, F Lipkin, W Li, ... Journal of the American College of Cardiology 63 (15), 1500-1509, 2014 | 107 | 2014 |
Use of real-world evidence to support FDA approval of oncology drugs BA Feinberg, A Gajra, ME Zettler, TD Phillips, EG Phillips Jr, JK Kish Value in Health 23 (10), 1358-1365, 2020 | 94 | 2020 |
Switching of adenosine diphosphate receptor inhibitor after hospital discharge among myocardial infarction patients: insights from the Treatment with Adenosine Diphosphate … ME Zettler, ED Peterson, LA McCoy, MB Effron, KJ Anstrom, TD Henry, ... American heart journal 183, 62-68, 2017 | 84 | 2017 |
Early medication nonadherence after acute myocardial infarction: insights into actionable opportunities from the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment … R Mathews, ED Peterson, E Honeycutt, CT Chin, MB Effron, M Zettler, ... Circulation: Cardiovascular Quality and Outcomes 8 (4), 347-356, 2015 | 83 | 2015 |
Association of discharge aspirin dose with outcomes after acute myocardial infarction: insights from the treatment with ADP receptor inhibitors: longitudinal assessment of … Y Xian, TY Wang, LA McCoy, MB Effron, TD Henry, RG Bach, ME Zettler, ... Circulation 132 (3), 174-181, 2015 | 67 | 2015 |
Treatment with adenosine diphosphate receptor inhibitors—longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) study design … CT Chin, TY Wang, KJ Anstrom, B Zhu, JF Maa, JC Messenger, KA Ryan, ... American heart journal 162 (5), 844-851, 2011 | 61 | 2011 |
Factors associated with clopidogrel use, adherence, and persistence in patients with acute coronary syndromes undergoing percutaneous coronary intervention B Zhu, Z Zhao, P McCollam, J Anderson, JP Bae, H Fu, M Zettler, ... Current medical research and opinion 27 (3), 633-641, 2011 | 46 | 2011 |
Impact of social determinants of health on cancer care: a survey of community oncologists ME Zettler, BA Feinberg, Y Jeune-Smith, A Gajra BMJ Open 11 (10), e049259, 2021 | 40 | 2021 |
Oxidized low-density lipoprotein retards the growth of proliferating cells by inhibiting nuclear translocation of cell cycle proteins ME Zettler, MA Prociuk, JA Austria, G Zhong, GN Pierce Arteriosclerosis, thrombosis, and vascular biology 24 (4), 727-732, 2004 | 37 | 2004 |
Unplanned inpatient and observation rehospitalizations after acute myocardial infarction: insights from the treatment with adenosine diphosphate receptor inhibitors … CN Hess, TY Wang, LA McCoy, JC Messenger, MB Effron, ME Zettler, ... Circulation 133 (5), 493-501, 2016 | 35 | 2016 |
Real-world adverse events associated with CAR T-cell therapy among adults age≥ 65 years ME Zettler, BA Feinberg, EG Phillips Jr, AJ Klink, S Mehta, A Gajra Journal of Geriatric Oncology 12 (2), 239-242, 2021 | 28 | 2021 |
MC-1 (pyridoxal 5′-phosphate): novel therapeutic applications to reduce ischaemic injury DE Kandzari, JP Dery, PW Armstrong, DA Douglas, ME Zettler, ... Expert Opinion on Investigational Drugs 14 (11), 1435-1442, 2005 | 27 | 2005 |
Effects of pyridoxal-5′-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized study JC Tardif, M Carrier, DE Kandzari, R Emery, R Cote, T Heinonen, ... The Journal of Thoracic and Cardiovascular Surgery 133 (6), 1604-1611. e1, 2007 | 26 | 2007 |
Cell cycle proteins and atherosclerosis ME Zettler, GN Pierce Herz 25, 100-107, 2000 | 26 | 2000 |
Multivessel Versus Culprit Vessel–Only Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction: Insights From the TRANSLATE‐ACS Observational Study H Ibrahim, PK Sharma, DJ Cohen, GC Fonarow, LA Kaltenbach, ... Journal of the American Heart Association 6 (10), e006343, 2017 | 25 | 2017 |
Early cessation of adenosine diphosphate receptor inhibitors among acute myocardial infarction patients treated with percutaneous coronary intervention: insights from the … EL Fosbøl, C Ju, KJ Anstrom, ME Zettler, JC Messenger, R Waksman, ... Circulation: Cardiovascular Interventions 9 (11), e003602, 2016 | 24 | 2016 |